Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy.

Bibliographic Details
Title: Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy.
Authors: Hoffman, Risa M, Brummel, Sean S, Britto, Paula, Pilotto, Jose H, Masheto, Gaerolwe, Aurpibul, Linda, Joao, Esau, Purswani, Murli U, Buschur, Shelley, Pierre, Marie Flore, Coletti, Anne, Chakhtoura, Nahida, Klingman, Karin L, Currier, Judith S, Team, PROMISE (Promoting Maternal and Infant Safety Everywhere) 1077HS
Source: Clinical Infectious Diseases; 1/15/2019, Vol. 68 Issue 2, p273-279, 7p
Subject Terms: CONFIDENCE intervals, FISHER exact test, EVALUATION of medical care, MISCARRIAGE, PERINATAL death, ANTIRETROVIRAL agents, RELATIVE medical risk, CD4 lymphocyte count, PREGNANCY
Abstract: Background Adverse pregnancy outcomes for women who conceive on antiretroviral therapy (ART) may be increased, but data are conflicting. Methods Human immunodeficiency virus–infected, nonbreastfeeding women with pre-ART CD4 counts ≥400 cells/μL who started ART during pregnancy were randomized after delivery to continue ART (CTART) or discontinue ART (DCART). Women randomized to DCART were recommended to restart if a subsequent pregnancy occurred or for clinical indications. Using both intent-to-treat and as-treated approaches, we performed Fisher exact tests to compare subsequent pregnancy outcomes by randomized arm. Results Subsequent pregnancies occurred in 277 of 1652 (17%) women (CTART: 144/827; DCART: 133/825). A pregnancy outcome was recorded for 266 (96%) women with a median age of 27 years (interquartile range [IQR], 24–31 years) and median CD4+ T-cell count 638 cells/μL (IQR, 492–833 cells/μL). When spontaneous abortions and stillbirths were combined, there was a significant difference in events, with 33 of 140 (23.6%) in the CTART arm and 15 of 126 (11.9%) in the DCART arm (relative risk [RR], 2.0 [95% confidence interval {CI}, 1.1–3.5]; P =.02). In the as-treated analysis, the RR was reduced and no longer statistically significant (RR, 1.4 [95% CI,.8–2.4]). Conclusions Women randomized to continue ART who subsequently conceived were more likely to have spontaneous abortion or stillbirth, compared with women randomized to stop ART; however, the findings did not remain significant in the as-treated analysis. More data are needed on pregnancy outcomes among women conceiving on ART, particularly with newer regimens. [ABSTRACT FROM AUTHOR]
Copyright of Clinical Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:10584838
DOI:10.1093/cid/ciy471
Published in:Clinical Infectious Diseases
Language:English